Profiel
Dr. Ross Chikarmane is an Associate at RA Capital Management LP.
He is an Associate with the TechAtlas division of RA Capital.
Ross works closely with members of the investment team and portfolio companies to deeply understand competitive landscapes, evaluate investment opportunities in a variety of therapeutic areas across all stages from discovery and new company creation through commercialization, and advise portfolio companies on program and pipeline strategy.
He has a BS in Biochemistry from University of Oregon and a PhD in Pharmacology & Molecular Sciences from Johns Hopkins University.
Actieve functies van Ross Chikarmane
Bedrijven | Functie | Begin |
---|---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Analyst-Equity | 01-05-2022 |
Opleiding van Ross Chikarmane
University of Oregon | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Finance |